Femtech
Search documents
On October 7, the Nasdaq Listing and Hearing Review Council affirmed a decision by the Nasdaq Hearing Panel to delist the Company's securities, based on a failure to meet the minimum bid price requirement, without having to decide on the issue of "public
Thenewswire· 2025-10-09 21:10
Core Viewpoint - Femto Technologies Inc. has been affirmed for delisting from the Nasdaq Stock Market due to non-compliance with the Minimum Bid Price requirement, as determined by the Nasdaq Listing and Hearing Review Council [1][2] Group 1: Delisting Decision - The Nasdaq Listing and Hearing Review Council upheld the decision of the Nasdaq Hearing Panel to delist Femto's securities based on technical reasons related to the company's failure to meet the Minimum Bid Price requirement [2] - The Council indicated that the violation of the Bid Price Rule was sufficient grounds for the delisting, without needing to assess public interest considerations [2] Group 2: Future Actions - The company is contemplating a request for the Nasdaq Board of Directors to review the Council's decision, as permitted under Nasdaq Rule 5825 [2] - Femto may also pursue a review with the Securities and Exchange Commission and federal courts, while exploring listing options on other stock exchanges [3] Group 3: Operational Continuity - Despite the delisting, the company is committed to executing its recovery plan aimed at improving its capital structure and will continue its research and development activities [3] - Femto plans to promote sales of its products as scheduled, indicating ongoing operational efforts [3] Group 4: Company Overview - Femto Technologies Inc. is a femtech company focused on wellness technology, emphasizing AI-driven solutions to enhance well-being through innovative product development [4]
Femto Technologies Announces Changes to its Board of Directors
Thenewswire· 2025-09-29 21:00
Core Insights - Femto Technologies Inc. has appointed Mor Bzizinsky to its board of directors, enhancing its governance with her legal and business expertise [1][2] - The company aims to leverage Bzizinsky's background to advance its entry into the Femtech market with innovative products [2] - Femto Technologies is focused on AI-driven solutions in wellness technology, aiming to improve well-being through intelligent technology integration [3] Company Overview - Femto Technologies Inc. is a cutting-edge femtech company dedicated to transformative advancements in wellness technology [3] - The company is known for its proprietary Smart Release System (SRS) technology, which incorporates machine learning and AI to enhance feminine wellness [4] - The Sensera device, a product of Femto, has been recognized as a CES Innovation Awards® 2025 Honorary in the AI category, highlighting its innovative approach to feminine wellness [4]
FEMTO Common Shares to Delist from Nasdaq as of June 23, 2025
Thenewswire· 2025-06-20 21:15
Core Viewpoint - Femto Technologies Inc. is set to be delisted from Nasdaq, transitioning to OTC trading under the symbol "FMTOF" starting June 23, 2025 [1] Company Overview - Femto Technologies Inc. is a pioneering Femtech company focused on wellness technology, emphasizing AI-driven solutions to enhance well-being [3] - The company was previously known as BYND Cannasoft Enterprises Inc. [1] Delisting and Future Plans - The Nasdaq Hearings Panel has determined to delist the company's common shares, but the company is exploring options including an appeal and potential listings on Canadian or European exchanges [2] - Despite the delisting, the company asserts that its stable financial condition will not affect its operations or business plan execution [2] Product Highlight - Sensera is a feminine wellness device developed by Femto Technologies, utilizing proprietary Smart Release System (SRS) technology, including machine learning and AI, to enhance feminine wellness [4]
FEMTO Receives Nasdaq Delisting Determination and Plans to Appeal
Thenewswire· 2025-05-09 21:20
Core Viewpoint - Femto Technologies Inc. has received a notification from Nasdaq regarding the delisting of its securities due to significant shareholder dilution resulting from a recent private placement transaction [1][2]. Group 1: Company Actions - The company intends to appeal Nasdaq's determination to a Hearings Panel, which will stay the suspension of its securities pending the Panel's decision [3]. Group 2: Company Background - Femto Technologies Inc. is a Femtech company focused on wellness technology, emphasizing AI-driven solutions to enhance well-being [4]. - The company is known for its product Sensera, a feminine wellness device that integrates machine learning and AI to provide a holistic self-care experience [5].
Femto Technologies Announces Reverse Split Implemented
Thenewswire· 2025-04-22 12:05
Core Viewpoint - Femto Technologies Inc. has implemented a 1-for-500 reverse stock split to comply with Nasdaq's minimum bid price requirement for continued listing [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split became effective on April 22, 2025, and was approved by the board on April 10, 2025 [1]. - Following the split, the number of issued and outstanding subordinate voting shares decreased from approximately 299,848,784 to about 599,697 [4]. - The trading of subordinate voting shares will continue under the symbol "FMTO" with a new CUSIP number 31447N303 [2]. Group 2: Impact on Shareholders - Every 500 subordinate voting shares will be combined into one, with fractional shares rounded down or up based on specific criteria [3]. - The reverse stock split will uniformly affect all shareholders without altering their relative interest in the company's equity, except for adjustments related to fractional shares [3]. Group 3: Company Overview - Femto Technologies Inc., formerly known as BYND Cannasoft Enterprises Inc., is a public company focused on female wellness and has developed the Sensera product [5]. - The company's Smart Release System (SRS technology) is recognized in the CES Innovation Awards® 2025 in the AI category [5]. - Current devices are in the early development stage and will require testing and regulatory approvals before market release [5].